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Objective: The definition of critical limb ischemia (CLI) requiring vascular intervention is still under debate. The clinical
eye of the physician and ankle blood pressure measurements used so far may fall short in appreciation of the severity of
disease, which makes decision-making for a vascular intervention subjective. In previous studies two simple functional
tests, ie, transcutaneous oxygen pressure (tcPO2) and toe blood pressure (TP) measurements, provided reliable informa-
tion about the need for vascular intervention. Therefore we evaluated the diagnostic value of tcPO2 and TP in
management of clinically suspected critical leg ischemia.
Study design: This was a diagnostic randomized controlled clinical trial. Subjects were ambulatory and hospitalized
patients in a referral university hospital.
Methods: Ninety-six patients (128 legs) with clinically suspected critical limb ischemia were referred to the vascular
laboratory for routine investigation. Two diagnostic management strategies were compared: conventional strategy, ie,
clinical judgment and ankle pressure determined the diagnostic and therapeutic approach, and a new strategy in which
tcPO2 and TP determined the diagnostic and therapeutic approach. Main outcome measures included clinical outcome,
defined as pain relief, wound healing, and limb survival.
Results: At 18-month follow-up, 26 of 62 legs treated with the conventional approach and 28 of 66 legs treated with the
new approach were treated conservatively. The new method did not score significantly different from the conventional
method insofar as clinical outcome: pain score, 50 versus 48; number of amputations, 8 versus 10; and number of deaths,
11 versus 8 deaths, respectively.
Conclusion: Two simple objective diagnostic tests, TP and tcPO2, did not improve clinical outcome when incorporated
into routine management of suspected critical limb ischemia. Nevertheless, these techniques might still be helpful for
physicians less experienced with treating critical limb ischemia and who are in doubt regarding the need for vascular
intervention. (J Vasc Surg 2003;38:528-34.)
The definition of critical leg ischemia (CLI) that re-
quires intervention is still under debate.1-7 According to
the TransAtlantic Inter-Society Consensus on Manage-
ment of Peripheral Arterial Disease the term CLI can be
used for all limbs with chronic ischemic rest pain, ulcer, or
gangrene, attributable to objectively proved arterial occlu-
sive disease.3 However, these clinical characteristics are not
specific for CLI, but can also be caused by other diseases.
Particularly in patients with multifactorial disease, eg, pe-
ripheral vascular disease in combination with diabetes or
venous insufficiency, the indication for intervention in sus-
pected CLI can be difficult. Various consensus documents
have proposed criteria based on ankle blood pressure (AP).
However, objective criteria have never achieved full con-
sensus.5-7 The latest consensus does not define objective
criteria for vascular intervention in clinically suspected CLI.
At present, diagnostic angiography or duplex scanning is
frequently performed to evaluate the extent of vascular
obstruction. The limitation of these investigations is that
they do not provide functional information about tissue
perfusion, but only anatomic information, which is not
always related to the severity of clinical symptoms and
clinical outcome of the disease.
Therefore the indication for vascular intervention is
frequently based on the skilled view of a vascular specialist.
The timing for vascular intervention is difficult, because
vascular intervention is accompanied by serious side effects,
eg, risk of operation, wound infection, and early occlusion,
ultimately resulting in amputation or death.8 In contrast,
postponing intervention can harm the patient. Moreover,
CLI has a considerable effect on health-related quality of
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life.9 This leads to considerable variation between diagnos-
tic procedures and indications for vascular intervention
between hospitals and countries.10,11
Hence there is need for simple objective criteria to
identify CLI that requires vascular intervention. Previous
investigations have shown retrospectively that a combina-
tion of toe blood pressure (TP) and transcutaneous oxygen
pressure (tcPO2) measurements might be good indicators
of CLI and subsequent need for vascular intervention.12,13
Both are simple, quick tests that provide functional infor-
mation about peripheral tissue perfusion. In actuality, it is
disturbance in the peripheral (micro)circulation that causes
signs and symptoms of CLI.7,14-16 Several studies have
demonstrated the diagnostic advantage of transcutaneous
oxygen measurements in evaluation of arterial insufficiency
of the leg.17-20 tcPO2 measurements may be used to direct
therapy, because they accurately predict the presence of
significant vascular disease.17 Moreover, additional mea-
surement of TP and tcPO2 substantially increases pretest
probability for vascular intervention.7
In the present diagnostic randomized clinical trial we
compared outcome in patients with clinically suspected
CLI managed with a new strategy, based on the combina-
tion of TP and tcPO2 measurements and on indication
duplex scans or angiograms, with that for CLI managed
with the conventional strategy, based on AP measurements
and duplex scans or angiograms.
PATIENTS AND METHODS
Patients. Inpatients and outpatients of the Academic
Medical Center seen from April 1, 1997, to June 1, 1999,
referred to the vascular laboratory for diagnostic work-up
by a vascular surgeon because of clinically suspected CLI,
were asked to participate in this diagnostic randomized
clinical trial. Clinical CLI was defined as pain at rest in the
lower leg for more than 2 weeks, ulcers that persisted for
more than 2 weeks, or diffuse gangrene of the forefoot.
Patients with suspected acute arterial occlusion were ex-
cluded. To improve the significance of this study we ex-
cluded the so-called clear-cut cases, leaving only patients
with an uncertain diagnosis, because only in these patients
was additional diagnostic effort relevant.21 Clear-cut cases
were defined as obviously severe disease, ie, presence of
extensive necrosis, or clearly mild disease, ie, presence of
clinical CLI but with palpable peripheral pulses.
Fig 1. Scheme of randomization and follow-up.
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Patients were randomized to receive either conven-
tional treatment or the new management technique (Fig
1), which could also have consequences for the therapy
assigned. The potential types of therapy were equivalent for
both groups (vascular intervention or conservative thera-
py), but the groups differed in diagnostic information
available at the time the decision was made. This differing
information could lead to a different treatment and might
influence clinical outcome in the end.
The randomization was performed by computer and
was prestratified for the presence of diabetes mellitus and
bilateral symptoms of CLI. If CLI was clinically suspected
in both of a patient’s legs, both legs were included in the
trial, but randomization was only assigned once.
Methods. AP was measured in all patients. TP and
tcPO2 were measured only in patients assigned to the new
strategy group. In the conventional strategy group TP was
also measured in patients with diabetes mellitus and pa-
tients in whom AP was not reliable because of incompress-
ible arteries (ankle-brachial index  115%), because with-
holding any functional information about severity of
disease would be unethical and unacceptable to the vascular
surgeons in our department. AP, TP (PV lab, Sto¨pler;
Electric Diagnostic Instruments, Burbank, Calif) and tcPO2
(TCM3; Radiometer, Copenhagen, Denmark) at electrode
temperature of 44°C were measured according to standard
procedures.14 The reproducibility of all techniques has
been studied and appears to be acceptable for all techniques
across the entire range of pressure.14
During follow-up of 18 months the diagnostic regimen
was based on assigned randomization, which might have
consequences for the assigned therapy and clinical out-
come. Appropriate measurements, ie, AP, TP, and tcPO2
and assessment of outcome parameters, were assessed at
regular intervals, ie, 1, 3, 6, 9, 12, and 18 months after
inclusion in the trial. The diagnostic and decision algorithm
for the patients is shown in Fig 1.
According to the conventional strategy, the decision
for further diagnostic imaging of the arteries, ie, primary
duplex scanning, was left to the discretion of the vascular
surgeon, based on clinical symptoms, findings at physical
examination, and AP, as well as TP in patients with incom-
pressible arteries. No specific levels were advocated. An-
giography, ie, intra-arterial digital subtraction angiogra-
phy, was performed only in patients with multilevel disease
or when it was not possible to evaluate the arteries because
of calcifications. The proposed therapy, whether conserva-
tive treatment, bypass grafting, or percutaneous translumi-
nal angioplasty, was discussed at a weekly multidisciplinary
meeting of vascular surgeons, intervention radiologists, and
vascular technologists. The decision was made on the basis
of consensus, and no specific AP or TP levels prompted
conservative treatment, arterial bypass grafting, or balloon
angioplasty.
According to the new strategy, the results of the com-
bination of TP and tcPO2 measurements indicated the
intention for vascular intervention. This intervention, and
therefore preintervention duplex scanning or angiography,






n % n %
Demographic
Age (y) 71  12 72  13
Male/female 29/17 29/21
Comorbidity
Diabetes mellitus 21 46 22 46
Hypertension 20 44 22 44
History of cerebrovascular
accident or transient ischemic
attack
11 24 12 24
History of coronary heart
disease
18 39 24 48
Vascular
Smoking 21 46 29 58
Two legs included 15 32 17 34
Pain and quality of life
SF-36 physical summary score 28  9 29  9
SF-36 mental summary score 41  12 41  12
SF-36 pain score 26  10 28  14







n % n %
Rest pain 54 87 57 86
Ulcerations or
gangrene
31 50 35 53
Previous minor
amputation
4 7 4 6
Previous bypass
operation
11 18 5 8
Previous PTA or TEA
procedure
11 18 10 15
Ankle systolic pressure
(mm Hg)
108  53 91  53
Ankle-brachial pressure
index
0.56  0.24 0.58  0.29
Toe pressure (mm Hg) 62  57* 45  42
TcPO2 (mm Hg) — 33  19
Pain and severity of
clinical symptoms
Visual analog scale
of pain in involved
leg
42  33 41  30
Wound surface
area (cm2)†
1.7 0.5-6.0 2.4 0.5-10.9
Knighton wound
severity score†
23 19-31 27 17-42
PTA, Percutaneous transluminal angioplasty; TEA, thromboendarterec-
tomy.
*Toe pressure measured in 15 legs with incompressible arteries.
†Median with interquartile ranges (25%-75%).
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was indicated only if one of the two measurements was
below the cutoff level (TP  30 mm Hg; tcPO2  35 mm
Hg) and symptoms of CLI were present. The final planning
of the vascular intervention, ie, indication and type, was
made at the vascular consensus meeting, with the intention
to perform every possible and clinical useful vascular inter-
vention to restore TP and tcPO2 measurements to above
the cutoff value.
Conservative treatment in both groups included con-
trol of pain; wound and foot care including appropriate
dressing, debridement, and topical antibiotic therapy; and
systemic antibiotic or anticoagulant therapy, if necessary.
On indication, diagnostic assessment for differential diag-
nosis was performed to rule out conditions such as diabetic
neuropathic ulcers, venous insufficiency, and nerve com-
pression, and appropriate treatment was administered.
Outcome parameters. The primary end point was
change in the clinical situation as noted by pain relief and
wound healing. Pain severity was appreciated for each leg
with a visual analog scale: the patient rates leg pain by
placing a mark on a line 100 mm long, with zero being
equivalent to no pain and 100 being equivalent to maxi-
mum pain. Next the pain was investigated in each patient
over the last month with the summary score of the pain
scale of the SF-36. This is calculated from two questions in
the questionnaire, and ranges from 0, representing maxi-
mum pain, to 100, representing no pain.3,22,23 The pres-
ence and severity of the wounds was graded by calculating
the Knighton wound severity score. This score is devised
from clinical (eg, periwound erythema, edema), anatomic
(eg, presence of exposed bone and tendon), and measured
(eg, surface area, depth) wound variables.24
Amputation was classified as minor amputation, ie,
retention of a sufficiently functional foot remnant to allow
standing and walking without a prosthesis, and major am-
putation, as suggested by Rutherford et al.4 The number of
diagnostic procedures, ie, duplex scanning and angiogra-
phy, irrespective of routine controls, was investigated.
Change in health-related quality of life was assessed with
the SF-36.3,25
Statistical analysis. Analysis was by intention of ran-
domization. Differences between groups were compared
with a t test, for continuous variables, and 2 test for
categorical data. Pain, quality of life, and severity of wounds
was assessed with univariate analysis of variance. The pres-
ence of wounds was assessed with the Student t test. Patient
survival was estimated with the Kaplan-Meier method, and
differences were evaluated with a log-rank test. Power
analysis was performed with the bodily pain subscale of the
SF36, and revealed that 90 patients must be included to
refute the null hypothesis that the diagnostic accuracy
between subgroups is the same (details of the calculation
and assumptions are presented elsewhere21).
RESULTS
Ninety-six patients with 128 legs with clinically sus-
pected CLI were randomly assigned to the conventional
treatment group (62 legs of 46 patients) or the new man-
agement strategy group (66 legs of 50 patients). During
the study 63 patients were excluded because of obviously
severe disease. The patients included in this trial were
referred to the vascular laboratory by a surgeon (62.7%),
dermatologist (16.2%), internist (14.2%), or others (4.4%).
Patient characteristics at baseline demonstrated no signifi-
cant differences between the two groups (Tables I and II).
Almost half of the patients had diabetes mellitus, hyperten-
sion, or history of coronary heart syndrome. Eighty-seven
percent of legs demonstrated symptoms of rest pain, and
50% had ulcerations or gangrene.
AP, ankle-brachial index, TP, and tcPO2 were high,
because only patients with an uncertain diagnosis were
included, with exclusion of clear cut cases (Table II). The
number of diagnostic procedures and vascular interven-
tions was not significantly different between the two man-
agement strategies (Table III). In 45% of patients a vascular
intervention was performed during the total observation
period. In 34 legs in the conventional strategy group and in
29 legs in the new strategy group (P  .11) a diagnostic
procedure was performed within 1 month after inclusion.
TP was measured in 15 of 62 legs (24%) of patients
assigned to the conventional strategy group. Eight of 46
patients in the conventional treatment group and 3 of 50
patients in the new treatment strategy group were lost to
follow-up (not significantly different); however, occurrence
of wounds or amputations in these patients was checked
with the general practitioner.
Over time, pain per involved leg did not differ signifi-
cantly between the two groups (P .9, Fig 2, A). The same
was true for pain in patients, as assessed with the SF-36 (P
 .07; Fig 2, B), although there was a tendency in favor of
the new strategy. The prevalence of wounds (P  .04; Fig
2, C) was significantly lower in the conventional treatment
group, whereas severity of wounds (P .55; Fig 2, D) was







n % n %
Minor amputation* 6 10 9 14 .59
Major amputation 3 5 4 6 .68
Number of patients who
underwent duplex scanning
or angiography
48 77 45 68 .24
Total duplex scans† 50 56
Total angiograms† 31 36
Number of patients with
vascular interventions




Bypass surgery† 18 18
*Minor amputations performed in patients who underwent major amputa-
tions not included.
†Multiple diagnostic procedures and interventions may be performed in one
patient.
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Fig 2. Graphic presentation of results of main outcome variables over time in patients in the new treatment group (solid
line) and conventional treatment group (dotted line). A, Pain score per leg per visual analog scale (0, no pain; 100,
maximum pain). B, Pain score per patient according to pain score of SF-36 scale (0, maximum pain; 100, no pain).
C, Percentage of patients with wounds. *P .04). D, Knighton wound severity score (0, minor superficial wound; 100,
severe clinical wound). E, Physical summary score of SF-36 (0, worst clinical situation; 100, best clinical situation).
F, Mental summary score of SF-36 (0, worst clinical situation; 100, best clinical situation. G, Kaplan-Meier plot of
patient survival. H, Kaplan-Meier plot of time to first vascular intervention.
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not significantly different. Quality of life assessed with the
SF-36 physical and mental summary score was not signifi-
cantly different between groups (P  .10 and P  .28,
respectively; Fig 2, E and F).
Kaplan-Meier estimate of patient survival was not sig-
nificantly different between the two groups (log-rank sta-
tistic, 0.12; P  .7; Fig 2, G). In both groups 12 patients
(25%) died during the study period. The number of major
and minor amputations and interventions did not differ
significantly between the two groups (Table III). No pa-
tients who received conservative treatment lost a limb to
amputation because of delay in intervention. Time to first
intervention was not significantly different (P  .9; Fig 2,
F).
DISCUSSION
Our data show that use of tcPO2 and TP measurements
in management of suspected CLI does not have advantage
over the clinical judgment of an experienced vascular sur-
geon. The therapeutic choice made did not lead to a better
clinical outcome in one strategy relative to the other.
Furthermore, the number of diagnostic procedures was not
reduced with use of these two objective measurements.
Apparently the clinical eye of an experienced physician can
also sufficiently appreciate the local (micro)circulation of
the endangered tissues of the distal leg, as do TP and tcPO2,
to plan the subsequent management policy.
Many previous studies have proposed use of tcPO2 and
TP in diagnosis of CLI requiring interven-
tion.12,13,16,20,26-29 However, a true reference standard for
CLI requiring vascular intervention does not exist; there-
fore TP or tcPO2 have been compared with substitute
reference standards like clinical indication for interven-
tion,12 wound healing,16,20,26,30 or outcome after revascu-
larization.27 Therefore we chose to evaluate the value of TP
and tcPO2 in relation to the diagnostic process and clinical
outcome in a diagnostic randomized clinical trial.21 A
randomized clinical trial is the highest standard in research.
A diagnostic randomized clinical trial not only evaluates the
effect on diagnosis, but also incorporates the total effect on
clinical outcome, eg, side effects of tests such as angiogra-
phy, and therapy, and use of the results by the physician.
The lack of a true reference standard makes a diagnostic
randomized clinical trial especially suitable in these cases.21
However, the diagnostic randomized clinical trial has
some disadvantages, eg, influence of treatment on out-
come, and the power and size of the trial. The expected
difference in clinical outcome between randomized groups
defines the size and power of the diagnostic randomized
clinical trial. Many factors influence outcome, eg, effect of
therapy and prevalence of the disease in the trial popula-
tion. Better diagnostic information may therefore not nec-
essarily lead to better therapeutic decisions or improvement
in clinical outcome. The availability of various therapies and
the capability of the physician to choose the better therapy
using the diagnostic information are prerequisite for better
outcome.
The present study included only patients with an un-
certain diagnosis, and excluded so-called clear-cut cases, ie,
patients with obviously severe or mild disease. Therefore
our study truly represents the population in whom the
diagnostic problem is relevant. This may also improve the
power of the study, because in these patients therapeutic
and clinical differences between management strategies are
more likely to appear.
It can be speculated that this study might fail to show
any difference because the potential value of TP is reduced
by applying TP also in patients in the conventional treat-
ment group who had incompressible arteries. However,
this was considered unavoidable because withholding func-
tional information about severity of disease in this group of
patients is unethical and was unacceptable to the vascular
surgeons in our department.
The present study did not show a reduction in the
number of diagnostic procedures with the new strategy.
The number of duplex scans with the new strategy might be
falsely elevated, because in a considerable number of pa-
tients no serious obstruction that required vascular inter-
vention could be identified at duplex scanning (n  15).
This could have been caused by our choice of a relatively
high and safe cutoff value for tcPO2 (35 mm Hg, rather
than 30 mm Hg or even 25 mm Hg),20 and the natural
variation of the measurements, which makes it likely that in
repeated measurements one of these values was below the
cutoff value.14 Measurements performed only on clinical
indication might reduce the number of false low pressures
considerably.
The question is whether there is still a place for use of
TP and tcPO2? We think that in selective cases these mea-
surements might still be of benefit. Especially, less experi-
enced physicians can use them as an aid to judging severity
of CLI. Furthermore, TP and tcPO2 measurements can
offer additional information to confirm the clinical diagno-
sis in doubtful situations. This is particularly the case when
AP is unreliable, eg, in patients with diabetes or when a leg
ulcer is caused by a combination of underlying pathologic
conditions. TP and tcPO2 could also be used as an objective
instrument in follow-up in clinical and research settings and
in individual cases. However, these factors were not evalu-
ated in the present study and need further evaluation.
We conclude that, although tcPO2 and TP measure-
ments provide additional information in selected cases,
routine incorporation of these diagnostic tools does not
lead to better patient outcome or reduction in the number
of diagnostic or therapeutic interventions in cases in which
the diagnosis of CLI is uncertain.
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